Insider Transactions

What Theravance Biopharma, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	8	19
Total trades	19	51

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 51 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Winningham Rick E	CHIEF EXECUTIVE OFFICER	Aug 20	Withheld — tax / exercise cost · F	−20,034	$16.95	−$340K	1,611,022
Sawaf Aziz	SVP & CHIEF FINANCIAL OFFICER	Aug 20	Withheld — tax / exercise cost · F	−8,112	$16.95	−$137K	336,841
Miller Aine	SVP, DEV & HEAD OF IRE OFFICE	Aug 20	Withheld — tax / exercise cost · F	−6,258	$16.95	−$106K	189,826
Grimaud Brett A.	SVP, GEN COUNSEL AND SECRETARY	Aug 20	Withheld — tax / exercise cost · F	−7,952	$16.95	−$135K	355,168
Farnum Rhonda	SVP, COMM & MEDICAL AFFAIRS	Aug 20	Withheld — tax / exercise cost · F	−5,667	$16.95	−$96.1K	226,790
Samaha Eli	10% owner	Jul 07	Open-market sale · S	−5,564	$17.17	−$95.5K	9,167,489
Samaha Eli	10% owner	Jul 06	Open-market sale · S	−1,400	$17.04	−$23.9K	9,173,053
Samaha Eli	10% owner	Jul 01	Open-market sale · S	−37,799	$17.00	−$643K	9,174,453
Samaha Eli	10% owner	Jun 30	Open-market sale · S	−25,027	$17.13	−$429K	9,212,252
Samaha Eli	10% owner	Jun 29	Open-market sale · S	−273,871	$17.23	−$4.72M	9,237,279
Miller Aine	SVP, DEV & HEAD OF IRE OFFICE	Jun 19	Grant / award · A	+18,750	—	—	196,084
Farnum Rhonda	SVP, COMM & MEDICAL AFFAIRS	Jun 15	Open-market sale · S	−6,657	$16.39	−$109K	232,457
Farnum Rhonda	SVP, COMM & MEDICAL AFFAIRS	Jun 15	Open-market sale · S	−3,328	$16.38	−$54.5K	239,114
Farnum Rhonda	SVP, COMM & MEDICAL AFFAIRS	Jun 15	Open-market sale · S	−3,329	$16.39	−$54.6K	242,442
Pakianathan Deepika	Director	Jun 12	Grant / award · A	+6,009	—	—	64,074
Mitchell Dean J	Director	Jun 12	Grant / award · A	+6,009	—	—	97,213
Smaldone Alsup Laurie	Director	Jun 12	Grant / award · A	+6,009	—	—	80,989
O'Connor Donal	Director	Jun 12	Grant / award · A	+6,009	—	—	80,213
Gray Susannah	Director	Jun 12	Grant / award · A	+6,009	—	—	48,146
Winningham Rick E	CHIEF EXECUTIVE OFFICER	May 20	Withheld — tax / exercise cost · F	−20,038	$16.55	−$332K	1,631,056

Page 1 of 33 · showing the 20 most recent Sign up free to view all 660 transactions and filter by insider →